Jaguar Health Statistics
Total Valuation
Jaguar Health has a market cap or net worth of $5.01 million. The enterprise value is $37.69 million.
Important Dates
The last earnings date was Thursday, May 15, 2025.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Jaguar Health has 1.26 million shares outstanding. The number of shares has increased by 934.82% in one year.
Current Share Class | 1.26M |
Shares Outstanding | 1.26M |
Shares Change (YoY) | +934.82% |
Shares Change (QoQ) | +31.57% |
Owned by Insiders (%) | 8.45% |
Owned by Institutions (%) | 5.53% |
Float | 1.02M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.15 |
Forward PS | 0.33 |
PB Ratio | 1.58 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 3.26 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 11.56.
Current Ratio | 1.08 |
Quick Ratio | 0.25 |
Debt / Equity | 11.56 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -459.52% and return on invested capital (ROIC) is -44.79%.
Return on Equity (ROE) | -459.52% |
Return on Assets (ROA) | -37.48% |
Return on Invested Capital (ROIC) | -44.79% |
Return on Capital Employed (ROCE) | -137.78% |
Revenue Per Employee | $235,755 |
Profits Per Employee | -$810,816 |
Employee Count | 49 |
Asset Turnover | 0.22 |
Inventory Turnover | 0.21 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.05% in the last 52 weeks. The beta is 0.96, so Jaguar Health's price volatility has been similar to the market average.
Beta (5Y) | 0.96 |
52-Week Price Change | -96.05% |
50-Day Moving Average | 6.55 |
200-Day Moving Average | 19.99 |
Relative Strength Index (RSI) | 32.98 |
Average Volume (20 Days) | 110,564 |
Short Selling Information
The latest short interest is 32,263, so 2.55% of the outstanding shares have been sold short.
Short Interest | 32,263 |
Short Previous Month | 114,446 |
Short % of Shares Out | 2.55% |
Short % of Float | 3.15% |
Short Ratio (days to cover) | 0.14 |
Income Statement
In the last 12 months, Jaguar Health had revenue of $11.55 million and -$39.73 million in losses. Loss per share was -$93.55.
Revenue | 11.55M |
Gross Profit | 9.51M |
Operating Income | -32.04M |
Pretax Income | -38.32M |
Net Income | -39.73M |
EBITDA | -30.16M |
EBIT | -32.04M |
Loss Per Share | -$93.55 |
Full Income Statement Balance Sheet
The company has $5.69 million in cash and $38.34 million in debt, giving a net cash position of -$32.65 million or -$25.81 per share.
Cash & Cash Equivalents | 5.69M |
Total Debt | 38.34M |
Net Cash | -32.65M |
Net Cash Per Share | -$25.81 |
Equity (Book Value) | 3.32M |
Book Value Per Share | 2.64 |
Working Capital | 2.23M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$29.65 million and capital expenditures -$16,000, giving a free cash flow of -$29.67 million.
Operating Cash Flow | -29.65M |
Capital Expenditures | -16,000 |
Free Cash Flow | -29.67M |
FCF Per Share | -$23.46 |
Full Cash Flow Statement Margins
Gross Margin | 82.34% |
Operating Margin | -277.33% |
Pretax Margin | -350.41% |
Profit Margin | n/a |
EBITDA Margin | -261.07% |
EBIT Margin | -277.33% |
FCF Margin | n/a |
Dividends & Yields
Jaguar Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -934.82% |
Shareholder Yield | -934.82% |
Earnings Yield | -787.36% |
FCF Yield | -587.97% |
Analyst Forecast
The average price target for Jaguar Health is $60.00, which is 1,415.15% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $60.00 |
Price Target Difference | 1,415.15% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on March 24, 2025. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Mar 24, 2025 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 4 |